THE OTHER ED ESTROGEN DEFICIENCY Trademark

Trademark Overview

On Tuesday, October 15, 2013, a trademark application was filed for THE OTHER ED ESTROGEN DEFICIENCY with the United States Patent and Trademark Office. The USPTO has given the THE OTHER ED ESTROGEN DEFICIENCY trademark a serial number of 86091631. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, September 1, 2015. This trademark is owned by Novo Nordisk FemCare AG. The THE OTHER ED ESTROGEN DEFICIENCY trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Providing medical information services for patients regarding estrogen deficiency and vaginal atrophy
the other ed estrogen deficiency

General Information

Serial Number86091631
Word MarkTHE OTHER ED ESTROGEN DEFICIENCY
Filing DateTuesday, October 15, 2013
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, September 1, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, September 2, 2014

Trademark Statements

Indication of Colors claimedThe color(s) light blue and dark blue is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"ESTROGEN DEFICIENCY"
Description of MarkThe mark consists of the wording "THE OTHER ED ESTROGEN DEFICIENCY", with the letters "THE OT" and "ESTROGEN DEFICIENCY" in dark blue and "HER ED" in light blue.
Goods and ServicesProviding medical information services for patients regarding estrogen deficiency and vaginal atrophy

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 22, 2013
Primary Code044
First Use Anywhere DateFriday, February 28, 2014
First Use In Commerce DateFriday, February 28, 2014

Trademark Owner History

Party NameNovo Nordisk FemCare AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressZurich CH-8050
CH
Party NameNovo Nordisk FemCare AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressZurich CH-8050
CH

Trademark Events

Event DateEvent Description
Wednesday, September 2, 2015ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, September 1, 2015ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, February 3, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 3, 2015NON-FINAL ACTION E-MAILED
Tuesday, February 3, 2015SU - NON-FINAL ACTION - WRITTEN
Wednesday, January 14, 2015STATEMENT OF USE PROCESSING COMPLETE
Tuesday, December 2, 2014USE AMENDMENT FILED
Monday, January 12, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 2, 2014TEAS STATEMENT OF USE RECEIVED
Tuesday, October 28, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 2, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 2, 2014PUBLISHED FOR OPPOSITION
Wednesday, August 13, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 29, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, July 25, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 23, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 22, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 22, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 6, 2014COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
Thursday, February 6, 2014ASSIGNED TO LIE
Thursday, February 6, 2014NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Thursday, February 6, 2014EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Thursday, February 6, 2014EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Thursday, January 30, 2014ASSIGNED TO EXAMINER
Tuesday, October 22, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, October 18, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

deficiency estrogen other vaginal atrophy regarding patients medical information services providing